Skip to main content
. 2021 Oct 17;11(10):1042. doi: 10.3390/jpm11101042

Figure 1.

Figure 1

Tracers developed for functional imaging of NETs. Legend: neuroendocrine tumour cell (NET CELL); 68Ga-NOTA-MAL-Cys39-exendin-4 (68Ga NMC39); glucagon-like peptide-1 receptor (GLP-1R); 123I metaiodobenzylguanidine (123I MIBG); norepinephrine transporter (NE); 99mTc labelled SA: 99mTc-EDDA-hydrazinonicotinyl-Tyr3-octreotate (99mTc-HYNIC-TATE) and 99mTc-EDDA-hydrazinonicotinyl-Tyr3-octreotide (99mTc-EDDA/HYNIC-TOC; 99mTc-TOC); 111In-diethylenetriaminepentaacetic acid-D-Phe1-octreotide (111In -DTPA-octreotide); 68Ga-labelled somatostatin analogs: 68Ga-DOTA-Phe1-Tyr3-Octreotide (DOTATOC), 68Ga-DOTA-Nal3 -Octreotide (DOTANOC), and 68Ga-DOTA-Tyr3-Octreotate (DOTATATE); somatostatin receptors (SST); 64Cu-DOTA-TATE (64Cu-TATE); 11C-5-hydroxytryptophan (11C-5HTP); L-type amino acid transporter (LAT); 6-Fluoro-(18F)-l-3,4-dihydroxyphenylalanine (18F-DOPA); L-[methyl-11C]-methionine (11C-MET); 18F-2-fluoro-2-deoxy-D-glucose (18FDG); glucose transporters (Glut).